1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT https://t.co/9qEUnPHc9G
Retrospective study: #Lobectomy superior to #Radiotherapy in #early-#stage #non-small-cell #lung #cancer (#NSCLC) / Albano et al. Lung Cancer (Auckl) 2018 https://t.co/ye03SSn8eW
RT @maraantonoff: What do you say @drnikkistamp ? Is there “peer review down under?” @DrewMoghanaki #lcsm #radonc https://t.co/sUwF0foPt7
What do you say @drnikkistamp ? Is there “peer review down under?” @DrewMoghanaki #lcsm #radonc
Surgery vs SBRT in stage I/II NSCLC. This retrospective analysis too supports the growing evidence in support of surgery compared to radiotherapy in this patient population. #lcsm #medtwitter https://t.co/hMv47xu24h
Today, it's surgery that looks better than SBRT. Note, this is written by an American group, but published in a New Zealand journal. Do they even have peer-review down under? #lcsm #radonc https://t.co/dnI4kYzR2Y https://t.co/IkFdtGKMxQ
1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT - Dove Medical Press https://t.co/vl7SwwVGS8 https://t.co/ubaPNCmqGJ